Genes Linked to Better Immune Response to Flu Vaccine Identified

Vaccination is the best way to protect against flu infection. However, the effectiveness of the vaccine varies widely among individuals.

Genes and gene clusters associated with the immune response to flu vaccination has been identified by a research team at the Yale University. The findings point to the prospect of using genetic profiles to predict individual responses to the flu vaccine.

Vaccination is the best way to protect against flu infection, yet effectiveness of the vaccine varies widely among individuals. To explore the role of genes in the immune response to flu vaccination, Yale researchers and their collaborators used data collected from more than 500 individuals who provided blood samples before and after being vaccinated.

Universal Flu Vaccine For Lifelong Protection May Soon Become Reality
Universal vaccine is the holy grail of immunization efforts against the flu, a shape-shifting virus which kills up to half a million people each year.

‘Genes that were associated with a stronger immune response to the flu vaccine were identified by an increase in antibodies that protect against infection.’

Analyzing the data, the research team identified several gene "signatures," or groups of genes, that were associated with a stronger response to the flu vaccine. The response was determined by increases in antibodies that protect against infection.

We "were able to identify genes at baseline, before vaccination, that would predict how individuals would respond to the vaccine," said Ruth Montgomery, associate professor of medicine at Yale School of Medicine and a co-author.

The researchers also found that the while the genes were predictive of a robust vaccine response in adults younger than age 35, those same genes did not improve responses in adults over age 60. "Another finding is that genes that contribute to good immune response are different in young and older people," Montgomery noted.

New Flu Vaccine can Reduce Risk of Serious Illnesses in Children
A new study reports on the results of a randomized, controlled study that has found that the flu vaccine is able to prevent the virus more than half the time in children.

"Surprisingly, we found that baseline differences, both at the gene and module level, were inversely correlated between young and older participants," added Steven Kleinstein, associate professor of pathology at Yale School of Medicine and a corresponding author on the study. The reasons for these age differences warrant further study, said the researchers.

The findings offer new insights into the biology of vaccine response. They may also help investigators predict responses in individuals and develop strategies to improve vaccines, Montgomery noted.

Single-shot Flu Vaccine may Provide Lifelong Protection Against Infectious Diseases
Lymphocyte T CD8+ cells of the immune system eliminates the virus-infected cells and retains memories of virus strains they encounter.

The researchers' analysis was based on data from the Human Immunology Project Consortium (HIPC) and the Center for Human Immunology (CHI), which include samples from individuals spanning a range of geographical locations and vaccination seasons. The initial findings were validated in an independent cohort of study subjects. All of the study data are available through the NIAID ImmPort repository and ImmuneSpace.

The research was published in Science Immunology.

Soon, New Nasal Spray Flu Vaccine Effective for Kids Under Two, Adults Over 49
Flu vaccines are less effective in people as they age and those over the age of 60 are more likely to get the flu and more likely to suffer serious complications.

Source-Eurekalert